DNDN Related Analyst PT Change

Jan 30, 2013 09:57 AM Cantor Fitzgerald Raises Estimates and PT on Dendreon (DNDN) Ahead of Q4

Sep 5, 2012 08:32 AM Cantor Fitzgerald Maintains a 'Hold' on Dendreon (DNDN); Near Term Not Pretty

Jul 31, 2012 02:37 PM Barclays Cuts Numbers on Dendreon (DNDN); Facing An Uphill Battle Just To Gain Traction

Jul 31, 2012 09:04 AM Canaccord Genuity Cuts PT and Estimates on Dendreon (DNDN); Going Off the Rails on a Crazy Train

Jul 31, 2012 07:37 AM Deutsche Bank Downgrades Dendreon (DNDN) to Hold; Sidelined as Gap in Sales Force to Delay Provenge Growth

Jul 31, 2012 07:04 AM Jefferies Cuts Numbers on Dendreon (DNDN) After Poor Q2

Jul 31, 2012 06:32 AM Baird Lower Numbers on Dendreon (DNDN) But Says Restructuring the Right Move

Jul 17, 2012 09:10 AM RBC Capital Negative on Dendreon (DNDN) Ahead of Q2 Results

Jun 4, 2012 09:05 AM Wedbush Reiterates an 'Underperform' on Dendreon (DNDN); New Treatments in Prostate Cancer Could Leave Provenge Behind

Jun 4, 2012 08:55 AM Baird Said Road Getting Tougher for Dendreon (DNDN)

Apr 12, 2012 09:52 AM Citi Cuts Dendreon (DNDN) Price Target to $10 Amid 'Significant Threats to Provenge'

Mar 9, 2012 08:59 AM Cantor Fitzgerald Maintains a 'Hold' on Dendreon (DNDN); Understanding Where A Catalyst For Valuation Expansion Will Come From

Feb 28, 2012 01:31 PM Canaccord Genuity Cuts Price Target on Dendreon (DNDN) After Q4, But Keeps Buy Rating

Feb 27, 2012 03:46 PM Baird Maintains a 'Neutral' on Dendreon (DNDN); Provenge Inflection Point Still Lacking

Feb 22, 2012 07:54 AM Citi Assumes Coverage on Dendreon (DNDN) at Neutral

Feb 7, 2012 08:28 AM Canaccord Genuity Raises Numbers on Dendreon (DNDN); Provenge Outlook Improved on Low Likelihood of New XGEVA Approval